China Pharma Providers
> Pharma China
> Product/R&D News
API/Bulk Drug News
People in the News
Top News Worldwide
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Beijing 100027, China
+86 10 84476010
+86 10 84476010
Chi-Med Initiates Sulfatinib Phase II Clinical Trial in Thyroid C...
AstraZeneca Files NDA for Possibly the First IBC-C Drug in China
BMS's Phase 3 Trial of All-Oral Chronic HCV Regimen Shows High Cu...
Amarantus Granted Chinese Patent Covering Use of MANF for Parkins...
USFDA Clears BeiGene's IND for Clinical Development of Anti-PD-1 ...
CANbridge Completes Chinese Glioblastoma Biomarker Study for Lead...
New Treatment for Alzheimer's Disease Enter Clinical Trial in Chi...
Yisheng Biopharma Reports Positive Phase I Results for New Rabies...
BeyondSpring Pharma Approved by CFDA to Initiate Global Phase III...
Chi-Med Initiates Phase III Trial of Sulfatinib for NETs in China...
Sinovac Approved to Initiate Clinical Trials of sIPV
Chi-Med Initiates Phase III Trial of Fruquintinib for NSCLC in Ch...
Shanghai Synthetic Biology Innovation Alliance Established
Nature's White Paper - Turning Point: Chinese Science in Transiti...
TaiGen's IV Taigexyn Achieved Primary Endpoint in Phase 3 Trial f...
CFDA Approves EV71 Vaccine against HFMD
HUYA Bioscience Announces Strategic Alliance With KDDF
China and New Zealand to Establish a Joint Medical Research Cente...
OncBioMune Granted Chinese Patent for Its Novel Cancer Vaccine
Domestic Companies Step Up Development of AD Drugs
British and Chinese Universities Sign MOU for Cancer Research Par...
Review of Drug Registration Applications in Q3/2015
Aoxing Pharma Receives China FDA Approval to Initiate Four Progra...
Review of Drug Registration Applications in H1/2015
CASI's Anticancer Gets Orphan Drug Designation from EMA
iBio Announces New Chinese Patent for iBioModulate Portfoilio
Ark Biosciences Announces Completion of Phase I Trials of Roche-l...
USFDA Confirms Luye Pharma's NDA Submission for LY03004 Without A...
RXi Pharma Granted Chinese Patent for Fibrosis Drug Candidate RXI...
Total number of articles:
© Wicon International Group Support by: